Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2497282 | 0.97 | — | — | |
| SCHEMBL2016344 | 0.95 | HRH3 (0.36) | CARM1PRMT6PRMT8LMNAKDM4E | |
| SCHEMBL48583 | 0.92 | — | — | |
| SCHEMBL4906908 | 0.86 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL347464 | 0.80 | LMNA (0.40) | CARM1PRMT6PRMT8LMNAALDH1A1 | |
| SCHEMBL762817 | 0.79 | KDM4E (0.36) | KDM4EALDH1A1KMT2A | |
| SCHEMBL346747 | 0.77 | HRH3 (0.43) | LMNAKDM4EALDH1A1L3MBTL1HRH3 | |
| SCHEMBL4814954 | 0.77 | KDM4E (0.36) | LMNAKDM4EALDH1A1 | |
| SCHEMBL2494508 | 0.77 | TSHR (0.35) | CARM1PRMT6PRMT8LMNAKDM4E | |
| SCHEMBL3305232 | 0.75 | TSHR (0.41) | LMNAKDM4EHTTALDH1A1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1698631-B1 | IONIC LIQUID, METHOD FOR PRODUCING SAME, DOUBLE LAYER CAPACITOR COMPRISING SAME, AND LITHIUM BATTERY | NAT INST OF ADVANCED IND SCIEN (JP) | 2011-08-10 | — | — | EP | disclosed |
| US-20070099079-A1 | Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2007-05-03 | — | — | US | disclosed |
| EP-1698631-A1 | IONIC LIQUID, METHOD FOR PRODUCING SAME, DOUBLE LAYER CAPACITOR COMPRISING SAME, AND LITHIUM BATTERY | National Institute of Advanced Industrial Science and Technology (JP) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099079-A1 | Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery | CLCN2, CACNA1F, CACNB3 | CARM1 756/4885PRMT6 1227/4885PRMT8 1177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.